Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;49(1):144-149.
doi: 10.4093/dmj.2024.0039. Epub 2024 Aug 28.

Effectiveness of Predicted Low-Glucose Suspend Pump Technology in the Prevention of Hypoglycemia in People with Type 1 Diabetes Mellitus: Real-World Data Using DIA:CONN G8

Affiliations

Effectiveness of Predicted Low-Glucose Suspend Pump Technology in the Prevention of Hypoglycemia in People with Type 1 Diabetes Mellitus: Real-World Data Using DIA:CONN G8

Jee Hee Yoo et al. Diabetes Metab J. 2025 Jan.

Abstract

We evaluated the effectiveness of the predictive low-glucose suspend (PLGS) algorithm in the DIA:CONN G8. Forty people with type 1 diabetes mellitus (T1DM) who used a DIA:CONN G8 for at least 2 months with prior experience using pumps without and with PLGS were retrospectively analyzed. The objective was to assess the changes in time spent in hypoglycemia (percent of time below range [%TBR]) before and after using PLGS. The mean age, sensor glucose levels, glucose threshold for suspension, and suspension time were 31.1±22.8 years, 159.7±23.2 mg/dL, 81.1±9.1 mg/dL, and 111.9±79.8 min/day, respectively. Overnight %TBR <70 mg/dL was significantly reduced after using the algorithm (differences=0.3%, from 1.4%±1.5% to 1.1%±1.2%, P=0.045). The glycemia risk index (GRI) improved significantly by 4.2 (from 38.8±20.9 to 34.6±19.0, P=0.002). Using the PLGS did not result in a change in the hyperglycemia metric (all P>0.05). Our findings support the PLGS in DIA:CONN G8 as an effective algorithm to improve night-time hypoglycemia and GRI in people with T1DM.

Keywords: Blood glucose; Continuous glucose monitoring; Diabetes mellitus, type 1; Hypoglycemia; Insulin infusion systems.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1.
Fig. 1.
Hypoglycemia metrics and glycemia risk index (GRI) before and after using the predictive low-glucose suspend (PLGS) algorithm: (A) percentage of time below range (%TBR) <70 mg/dL, (B) %TBR <54 mg/dL, (C, D) GRI. Values are statistically significant when analyzed with the paired t-test and Wilcoxon signed-rank test.
None

Similar articles

References

    1. Davis SN, Duckworth W, Emanuele N, Hayward RA, Wiitala WL, Thottapurathu L, et al. Effects of severe hypoglycemia on cardiovascular outcomes and death in the Veterans Affairs Diabetes Trial. Diabetes Care. 2019;42:157–63. - PMC - PubMed
    1. Varghese JS, Ho JC, Anjana RM, Pradeepa R, Patel SA, Jebarani S, et al. Profiles of intraday glucose in type 2 diabetes and their association with complications: an analysis of continuous glucose monitoring data. Diabetes Technol Ther. 2021;23:555–64. - PMC - PubMed
    1. The DCCT Research Group Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991;90:450–9. - PubMed
    1. Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care. 1997;20:22–5. - PubMed
    1. Abraham MB, de Bock M, Paramalingam N, O’Grady MJ, Ly TT, George C, et al. Prevention of insulin-induced hypoglycemia in type 1 diabetes with predictive low glucose management system. Diabetes Technol Ther. 2016;18:436–43. - PubMed

MeSH terms